quinazolines has been researched along with telcagepant in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (53.85) | 29.6817 |
2010's | 12 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arndt, K; Doods, H; Just, S; Rudolf, K | 1 |
Edvinsson, L; Kuris, A; Link, AS | 1 |
Ashina, M; Jensen, RH | 1 |
Stillman, MJ; Tepper, SJ | 1 |
Davis, CD; Xu, C | 1 |
Benemei, S; Capone, JG; Geppetti, P; Nicoletti, P | 1 |
Burgey, CS; Salvatore, CA; Williams, TM | 1 |
Nieber, K | 1 |
Tfelt-Hansen, PC | 1 |
Olesen, J; Villalón, CM | 1 |
Bigal, ME; Ho, TW | 1 |
Vetter, C | 1 |
Barwell, J; Donnelly, D; Garland, SL; Miller, PS; Poyner, DR; Wigglesworth, MJ | 1 |
Paone, DV; Staas, DD | 1 |
Paemeleire, K; Schelstraete, C | 1 |
Gingell, JJ; Hay, DL; Kane, SA; Moore, EL; Salvatore, CA | 1 |
Edvinsson, L; Ho, TW | 1 |
Durham, PL; Vause, CV | 1 |
Fischer, MJ | 1 |
Abdul-Manan, N; Coll, JT; Garcia-Guzman, M; Koth, CM; Lepre, CA; Lippke, JA; Moore, JM; Swenson, L; ter Haar, E | 1 |
Olesen, J; Tfelt-Hansen, P | 1 |
Lionetto, L; Martelletti, P; Negro, A; Simmaco, M | 1 |
Edvinsson, L; Warfvinge, K | 1 |
Anderson, C; Bergeron, D; Binch, H; Decker, C; Garcia-Guzman, M; Hadida, S; Joshi, P; Moore, J; terHaar, E; Termin, A; Yoo, S | 1 |
Abdolalizadeh, B; Amandi, N; Edvinsson, L; Pickering, DS; Pla, MV; Sams, A; Sheykhzade, M; Warfvinge, K | 1 |
Goadsby, PJ; Messina, R | 1 |
16 review(s) available for quinazolines and telcagepant
Article | Year |
---|---|
CGRP antagonists: unravelling the role of CGRP in migraine.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Models, Biological; Molecular Structure; Quinazolines | 2007 |
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Arteries; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Trigeminal Nerve; Tryptamines; Vasodilation | 2008 |
Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Drug Evaluation, Preclinical; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines | 2008 |
The tortuous road to an ideal CGRP function blocker for the treatment of migraine.
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Structure-Activity Relationship; Vasodilation | 2008 |
CGRP receptors in the control of pain and inflammation.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Neurogenic Inflammation; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2009 |
Calcitonin gene-related peptide receptor antagonists for the treatment of migraine.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Drug Design; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Species Specificity; Structure-Activity Relationship | 2009 |
[CGRP antagonists: novel concept for treatment of migraine].
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2009 |
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
Topics: Analgesics; Animals; Azepines; Brain; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Delivery Systems; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2009 |
Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Design; Drug Industry; Humans; Imidazoles; Migraine Disorders; Patents as Topic; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2009 |
CGRP antagonists: hope for a new era in acute migraine treatment.
Topics: Azepines; Brain; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines | 2009 |
CGRP receptor antagonism and migraine.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Neurotransmitter Agents; Piperazines; Quinazolines | 2010 |
Calcitonin gene-related peptide receptor antagonists for migraine.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Indazoles; Migraine Disorders; Piperazines; Quinazolines; Quinazolinones; Treatment Outcome; Trigeminal Nerve | 2010 |
Possible site of action of CGRP antagonists in migraine.
Topics: Animals; Azepines; Blood-Brain Barrier; Bridged Bicyclo Compounds, Heterocyclic; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebrovascular Circulation; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Spiro Compounds | 2011 |
CGRP receptor antagonists: an expanding drug class for acute migraine?
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Design; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Tryptamines | 2012 |
CGRP receptor antagonism and migraine therapy.
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Peptide Fragments; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2013 |
CGRP - a target for acute therapy in migraine: Clinical data.
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials, Phase II as Topic; Dipeptides; Drug Delivery Systems; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2019 |
10 other study(ies) available for quinazolines and telcagepant
Article | Year |
---|---|
[A new therapeutic principle for migraine].
Topics: Azepines; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents | 2008 |
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Arteries; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Serotonin Receptor Agonists; Treatment Failure; Tryptamines | 2009 |
Is there an inherent limit to acute migraine treatment efficacy?
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Drug Administration Schedule; Endpoint Determination; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines | 2009 |
[Migraine can signal a risk for heart and brain].
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Female; Humans; Imidazoles; Migraine Disorders; Migraine with Aura; Myocardial Infarction; Piperazines; Quinazolines; Risk Factors; Stroke; Tryptamines | 2009 |
Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Methionine; Piperazines; Protein Structure, Tertiary; Quinazolines; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Tryptophan | 2010 |
Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Crystallography, X-Ray; Dipeptides; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Migraine Disorders; Piperazines; Protein Interaction Domains and Motifs; Protein Interaction Mapping; Quinazolines; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Tryptophan | 2010 |
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Treatment Outcome | 2010 |
Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
Topics: Azepines; Binding Sites; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Crystallography, X-Ray; Imidazoles; Piperazines; Protein Structure, Tertiary; Quinazolines; Receptors, Calcitonin Gene-Related Peptide | 2010 |
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Dipeptides; Humans; Imidazoles; Inhibitory Concentration 50; Migraine Disorders; Molecular Structure; Molecular Weight; Piperazines; Protein Binding; Quinazolines; Quinazolinones; Rats; Receptors, Calcitonin Gene-Related Peptide; Thiazolidinediones; Urea | 2014 |
Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
Topics: Aged; Aged, 80 and over; Animals; Azepines; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Cerebellum; Cerebral Arteries; Dipeptides; Dose-Response Relationship, Drug; Endothelial Cells; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myography; Piperazines; Piperidines; Protein Binding; Pyridines; Quinazolines; Radioligand Assay; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptors, Calcitonin Gene-Related Peptide; Spiro Compounds; Sus scrofa; Vasodilation; Vasodilator Agents | 2017 |